Back to Journals » Lung Cancer: Targets and Therapy » Volume 13

Review

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC

       
Total article views   HTML views PDF downloads Totals
6,709 Dovepress* 6,316+ 329 6,645
PubMed Central* 393 162 555
Totals 6,709 491 7,200
*Since 19 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 1 2

View citations on PubMed and Google Scholar